Structures and mechanism of action of Comp-NPs for the diagnosis by imaging and treatment of tumors by multimodal photodynamic therapy and immunotherapy. a) Chemical structures of a polymer incorporating a chromophore for imaging upon irradiation at 808?nm (P1) or a photosensitizer for PDT upon irradiation at 650?nm (P2). b) Self-assembly of the polymers into the nanoparticles NP1 and NP2. The theranostic nanoparticle formulation Comp-NPs is generated by mixing NP1 and NP2. c) Biological mechanism of action of Comp-NPs by combined photodynamic therapy and immunotherapy.
Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-40826-5
An international research team headed by Dr. Johannes Karges of the Faculty of Chemistry and Biochemistry at Ruhr University Bochum, Germany, has developed nanoparticles that accumulate in cancer cells and eliminate them after being photoactivated.
In addition, they label them in such a way that immune cells learn to eliminate similar cells throughout the body. This means that even undetected metastases can be treated. The researchers presented their findings in the journal Nature Communications of 2 September 2023.
The malicious nature of cancers means that they spread throughout the body: cells from the primary tumor grow into surrounding tissue and travel through the bloodstream and lymphatic system to distant organs, where they form secondary metastatic tumors. “While we now have effective methods to combat primary tumors, metastases are still very difficult to treat,” explains Johannes Karges. “Ninety percent of people who die from cancer die from metastases and tumor regression, not from the primary tumor.”
Together with an international team, he’s developed a drug packaged in nanoparticles that are administered into the bloodstream. “Tumors grow rapidly and uncontrollably, and their tissue is therefore leaky,” he describes. “Unlike in healthy tissues, the nanoparticles therefore accumulate in them easily.” This also means that the particles preferentially accumulate in tumor cells.
Step one: treating a known tumor
At the time of administration, the drug is still ineffective. It only takes effect when activated with light. If there are sufficient nanoparticles in a detected tumor, they can be activated by irradiation with light, for example during surgery. After this energy supply, the active species ensures that immunogenic cell death occurs: the tumor cells containing the photoactivated nanoparticles are eliminated, and the tumor treated by this method disappears.
Step two: sending immune cells on a search
But that’s not all: the nanoparticles and their light-induced effect cause massive oxidative stress in the endoplasmic reticulum of the cells of the treated tumor. “This alerts the body’s own immune system,” explains Johannes Karges. “The immune cells recognize that something is going completely wrong in cells of this type, and that such cells therefore need to be eliminated.” This applies not only to the cells of the photo-treated tumor itself, but to all cells of the same kind throughout the body. “Accordingly, the immune system starts looking for further metastases and renders them harmless,” says Johannes Karges.
The research team proved this active principle in experiments on cancer cells and in animal models. They applied it to effectively treat mice that had been implanted with cells from metastasized and incurable human tumors. “Now, we’re looking for industrial partners who will help us undertake more in-depth studies,” says Johannes Karges. He expects that several more years of development work will be needed before the technology can be widely used in clinical applications.
Original Article: New compound unleashes the immune system on metastases
More from: Ruhr University Bochum
The Latest Updates from Bing News
Go deeper with Bing News on:
- Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients
ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research ...
- NIH awards merit grant for nanofiber research targeting metastatic lung tumors
Dr. Vanessa Bellat, an assistant professor of chemistry in radiology and an affiliate of the Molecular Imaging Innovations Institute (MI3) at Weill Cornell Medicine, has been awarded a $2 million, ...
- Allegheny Health Network site of study for pancreatic cancer treatment
Allegheny Health Network is working with a Florida pharmaceutical company for a Phase 1/2 clinical study of a new treatment for metastatic pancreatic cancer. Cantex Pharmaceuticals Inc. of Weston, ...
- New breast cancer treatment not approved for NHS use
New breast cancer treatment not approved for NHS use - The health spending watchdog said the ‘the cost-effectiveness estimates were too high for it to be recommended for use in the NHS’.
- FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients
The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's (NASDAQ: CHRS) on-body injector (OBI) presentation of ...
Go deeper with Bing News on:
- Evaluation of the Liver for Metastatic Disease
Most metastatic deposits are solid and mainly hypoechoic relative to the background liver (Fig. 4). Many will exhibit a hypoechoic "halo" (Fig. 5). There is some controversy as to whether the halo ...
- Brain Metastases From Prostate Cancer
Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.
- Metastases Spinal Tumor Market (New Report) Size, Trends Across Globally | 2023-2031
"Metastases Spinal Tumor Market" Size, Share, Growth Report 2023-2031 | | No. of pages: 102 Report which offers an in-depth analysis Grounded on Applications (Hospital And Clinics, Ambulatory ...
- New Compound Unleashes the Immune System on Metastases
This means that even undetected metastases can be treated. The researchers presented their findings in the journal Nature Communications of 2 September 2023. The malicious nature of cancers means that ...
- What to know about metastatic breast cancer in bones
Metastatic breast cancer in the bones originates from breast tissue but spreads to the bones. It is an advanced form of cancer. Treatments involve managing symptoms rather than curing the cancer ...